<HashMap><database>ENA</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR285/062/SRR28552162/SRR28552162_2.fastq.gz</Fastqsanger.gz><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR285/063/SRR28552163/SRR28552163_2.fastq.gz</Fastqsanger.gz><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR285/066/SRR28552166/SRR28552166_2.fastq.gz</Fastqsanger.gz><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR285/067/SRR28552167/SRR28552167_2.fastq.gz</Fastqsanger.gz><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR285/066/SRR28552166/SRR28552166_1.fastq.gz</Fastqsanger.gz><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR285/064/SRR28552164/SRR28552164_2.fastq.gz</Fastqsanger.gz><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR285/063/SRR28552163/SRR28552163_1.fastq.gz</Fastqsanger.gz><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR285/065/SRR28552165/SRR28552165_1.fastq.gz</Fastqsanger.gz><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR285/062/SRR28552162/SRR28552162_1.fastq.gz</Fastqsanger.gz><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR285/067/SRR28552167/SRR28552167_1.fastq.gz</Fastqsanger.gz><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR285/064/SRR28552164/SRR28552164_1.fastq.gz</Fastqsanger.gz><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR285/065/SRR28552165/SRR28552165_2.fastq.gz</Fastqsanger.gz></files><type>primary</type></body><statusCode>OK</statusCode><statusCodeValue>200</statusCodeValue></file_versions><scores/><additional><omics_type>Genomics</omics_type><center_name>University of Tsukuba</center_name><full_dataset_link>https://www.ebi.ac.uk/ena/browser/view/PRJNA1096120</full_dataset_link><long_description>Hypertrophic cardiomyopathy (HCM) is an inherited cardiac disorder characterized by ventricular wall hypertrophy and diastolic dysfunction. Most patients with HCM are often a slowly progressive disease and may be asymptomatic however, some progress to the dilated phase of HCM (D-HCM), and have a poorer prognosis. This study established disease-specific human induced pluripotent stem cells (iPSCs) from a patient with D-HCM harboring a truncating mutation in MYBPC3, and compared transcriptomes of iPSCs-derived cardiomyocytes between healthy control and D-HCM.</long_description><repository>ENA</repository><description_synonyms>Heart, Heart Muscle Cells, human being, Man (Taxonomy), Modern, Myocyte, Cardiac Myocytes, Heart Muscle, HCM - hypertrophic cardiomyopathy, patient, Cardiac Muscle Cells, Muscle Cells, Cardiac Muscle Cell, cardiocyte, Client, human, Cell, Human, Heart Muscle Cell, Cardiac Muscle, Cardiac, iPSC, Homo sapiens, Cardiomyocytes, Patient, Clients, Modern Man, cardiac muscle fiber, cardiac muscle cell, cardiac myocyte, Cells, heart muscle cell, Cardiac Myocyte, Cardiomyocyte, iPS cell, cardiomyocyte, Man, Muscle Cell, humans, familial hypertrophic cardiomyopathy.</description_synonyms></additional><is_claimable>false</is_claimable><name></name><description>Human iPSC-derived cardiomyocyte from a patient with D-HCM</description><dates><last_updated>2024-04-07</last_updated><first_public>2024-04-07</first_public></dates><accession>PRJNA1096120</accession><cross_references/></HashMap>